Skip to main content

Table 1 Patient demographics

From: Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer

Characteristic   N pCR rate
All Patients 26 46.2%
Race White 19 52.6%
African American 6 16.7%
Hispanic 1 100%
Age (years) Median 48  
Range 32–70  
ECOG performance status 0 21 47.6%
1 5 40%
Menopause status Pre-menopausal 16 37.5%
Post-menopausal 7 85.7%
Unknown 3 0%
Tumor size (cm) Median 2.8  
Range 0.6–8.7  
Clinical node stage 0 14 35.7%
1 11 54.5%
2 1 100%
Clinical stage IA 1 100%
IIA 14 35.7%
IIB 8 50%
IIIA 3 66.7%
Grade 1 0  
2 7 0%
3 17 63.2%
Receptor status HR+ and HER-2- 8 37.5%
HR+ and HER-2+ 3 33.3%
HR- and HER-2+ 4 75%
Triple Negative 11 45.5%